圓壹智慧是一家擁有快速、自主進(jìn)化的AI藥物設(shè)計(jì)平臺(tái)的新一代生物技術(shù)公司。其第三代AI系統(tǒng)為小分子、抗體和其他復(fù)雜治療方式提供極速虛擬篩選和多目標(biāo)藥理學(xué)優(yōu)化的解決方案。該平臺(tái)能在幾小時(shí)內(nèi)計(jì)算篩選多達(dá)10的十次方個(gè)蛋白質(zhì)序列或化合物，最終篩選出的候選化合物，其實(shí)驗(yàn)驗(yàn)證率顯著高于傳統(tǒng)方法所得，極大縮短了發(fā)現(xiàn)周期和成本。詳情請(qǐng)?jiān)L問(wèn)ainnocence.cn。
Ainnocence is a next-generation biotech company with a fast, self-evolving AI drug design platform. The company's third-generation AI system delivers lightning-fast virtual screening and multi-objective pharmacological profile optimization for small-molecule, antibody, and other complex therapeutic modalities. This platform provides a computational screening capacity of up to 10^10 protein sequences or chemical compounds within hours. The end results are a shortlist of candidates with a very high wet-lab hit rate, and a dramatically reduced discovery time and cost. To learn more, visit ainnocence.com.
?